October 2024: Lipids pathway update

We’ve come across some issues where patients have been sent the questionnaire about reviewing their statins and have got confused. They thought they were agreeing to a change of statin, and then weren’t happy when they had a dose increase. We also noticed a reduction in the number of patients agreeing to a change of statin since the questionnaire just said a dose increase.

We’ve now split this pathway in two:

1. Those on Atorva or Rosuva who could have a dose increase are sent a simpler questionnaire which only offers a dose increase
   1. To send, patients now appear in this report for this preset - 4) SEND - Comms Annex Preset "Lipids - Statin Dose Increase" (A/S) - add code XaCmC            ***NEW***
   2. To process those agreeing to a dose increase - *** PHARMACIST TO ACTION: Increase Statin Dose        ***NEW***
   3. If they want to discuss, it goes into the same report as previously - *** PHARMACIST TO CALL: Re: Statin Change / Dose Increase

Hopefully these are a little quicker to process and cause fewer issues.

2. Those on other statins, like Simva, Prava, etc will get the same questionnaire as before which asks for consent for the practice to review / change as appropriate. These patients appear in the same reports that were used previously
3. It varies between practices but its likely at least 2/3rds of patients will be appropriate for the dose increase questionnaire

Tips to save time…

1. If you haven’t already, would really recommend asking TPP to enable auto-reviewing for you and then we can get you using the rules we’ve created to bulk file all the lipids appropriately.
2. Use this button when you’re starting someone on a statin -  It will add Atorva 20 to their repeats, add notes about why its been done and offer to inform the patient